Human genetics of diabetic nephropathy

References

• Rema M, Premkumar S, Anitha B, et al. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci. 2005;46:2328–2333
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2994;27:1047–1053
   Google Scholar
• Jones CA, Krolewski AS, Rogus J, et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? Kidney Int. 2005;67:1684–1691
   PubMed Web of Science ®Google Scholar
• Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U.S. adults? Diabetes Care. 2008;31:81–86
   PubMed Web of Science ®Google Scholar
• Bowden DW. Genetics of diabetes complications. Curr Diab Rep. 2002;2:191–200
   PubMedGoogle Scholar
• Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39:940–945
   PubMed Web of Science ®Google Scholar
• Fogarty DG, Rich SS, Hanna L, Warram JH, Krolewski AS. Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure. Kidney Int. 2000;57:250–257
   PubMedGoogle Scholar
• Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516–1517
   PubMed Web of Science ®Google Scholar
• Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307:384–387
   PubMed Web of Science ®Google Scholar
• Gray SG, De Meyts P. Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab Res Rev. 2005;21:416–433
   PubMed Web of Science ®Google Scholar
• Greenberg DA. Linkage analysis of “necessary” disease loci versus “susceptibility” loci. Am J Hum Genet. 1993;52:135–143
   PubMedGoogle Scholar
• Remmers EF, Griffiths MM, Longman RE, et al. An integrated rat genetic map: Analysis of linkage conservation with the mouse and human maps. Transplant Proc. 1999;31:1549–1554
   PubMedGoogle Scholar
• Greenberg DA, Abreu PC. Determining trait locus position from multipoint analysis: Accuracy and power of three different statistics. Genet Epidemiol. 2001;21:299–314
   PubMedGoogle Scholar
• Terwilliger JD, Zollner S, Laan M, Paabo S. Mapping genes through the use of linkage disequilibrium generated by genetic drift: ‘Drift mapping’ in small populations with no demographic expansion. Hum Hered. 1998;48:138–154
   PubMed Web of Science ®Google Scholar
• Hodge SE, Anderson CE, Neiswanger K, Sparkes RS, Rimoin DL. The search for heterogeneity in insulin-dependent diabetes mellitus (IDDM): Linkage studies, two-locus models, and genetic heterogeneity. Am J Hum Genet. 1983;35:1139–1155
   PubMedGoogle Scholar
• Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet. 1990;46:229–241
   PubMed Web of Science ®Google Scholar
• Weber JL. Human DNA polymorphisms and methods of analysis. Curr Opin Biotechnol. 1990;1:166–171
   PubMedGoogle Scholar
• Davies JL, Kawaguchi Y, Bennett ST, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 1994;371:130–136
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Kraft P. Drinking from the fire hose – statistical issues in genomewide association studies. N Engl J Med. 2007;357:436–439
   PubMed Web of Science ®Google Scholar
• Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science. 2002;298:2345–2349
   PubMed Web of Science ®Google Scholar
• Imperatore G, Hanson RL, Pettitt DJ, et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes. 1998;47:821–830
   PubMed Web of Science ®Google Scholar
• Vardarli I, Baier LJ, Hanson RL, et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int. 2002;62:2176–2183
   PubMed Web of Science ®Google Scholar
• Tanaka N, Babazono T, Saito S, et al. Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms. Diabetes. 2003;52:2848–2853
   PubMed Web of Science ®Google Scholar
• Bowden DW, Colicigno CJ, Langefeld CD, et al. A genome scan for diabetic nephropathy in African Americans. Kidney Int. 2004;66:1517–1526
   PubMed Web of Science ®Google Scholar
• Krolewski AS, Poznik GD, Placha G, et al. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int. 2006;69:129–136
   PubMed Web of Science ®Google Scholar
• Iyengar SK, Abboud HE, Goddard KA, et al. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: The family investigation of nephropathy and diabetes (FIND). Diabetes. 2007;56:1577–1585
   PubMed Web of Science ®Google Scholar
• Rogus JJ, Poznik GD, Pezzolesi MG, et al. High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: Discordant sibpair approach. Diabetes. 2008;57:2519–2526
   PubMedGoogle Scholar
• Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: Results of novel discordant sib-pair analysis. Diabetes. 1998;47:1164–1169
   PubMed Web of Science ®Google Scholar
• Hodge SE. What association analysis can and cannot tell us about the genetics of complex disease. Am J Med Genet. 1994;54:318–323
   PubMedGoogle Scholar
• Brookes AJ. The essence of SNPs. Gene. 1999;234:177–186
   PubMed Web of Science ®Google Scholar
• Laan M, Paabo S. Mapping genes by drift-generated linkage disequilibrium. Am J Hum Genet. 1998;63:654–656
   PubMedGoogle Scholar
• Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606
   PubMed Web of Science ®Google Scholar
• International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299–1320
   PubMed Web of Science ®Google Scholar
• Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet. 2007;8:657–662
   PubMed Web of Science ®Google Scholar
• Canani LH, Capp C, Ng DP, et al. The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes. Diabetes. 2005;54:3326–3330
   PubMed Web of Science ®Google Scholar
• Canani LH, Costa LA, Crispim D, et al. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of type 2 diabetes. Diabet Med. 2005;22:1167–1172
   PubMedGoogle Scholar
• Ng DP, Tai BC, Koh D, Tan KW, Chia KS. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: A meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia. 2005;48:1008–1016
   PubMed Web of Science ®Google Scholar
• Perassolo MS, Almeida JC, Pra RL, et al. Fatty acid composition of serum lipid fractions in type 2 diabetic patients with microalbuminuria. Diabetes Care. 2003;26:613–618
   PubMedGoogle Scholar
• Yip J, Mattock MB, Morocutti A, et al. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet. 1993;342:883–887
   PubMedGoogle Scholar
• Groop L, Ekstrand A, Forsblom C, et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:642–647
   PubMed Web of Science ®Google Scholar
• Pizzuti A, Frittitta L, Argiolas A, et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes. 1999;48:1881–1884
   PubMed Web of Science ®Google Scholar
• Canani LH, Ng DP, Smiles A, et al. Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes. 2002;51:1188–1193
   PubMed Web of Science ®Google Scholar
• Santos KG, Canani LH, Gross JL, et al. Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients. J Nephrol. 2005;18:733–738
   PubMed Web of Science ®Google Scholar
• Pezzolesi MG, Poznik GD, Mychaleckyj JC, et al. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes. 2009;58:1403–1410
   PubMed Web of Science ®Google Scholar
• Maeda S, Araki S, Babazono T, et al. Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes. 2010;59:2075–2079
   PubMed Web of Science ®Google Scholar
• Hoover KB, Bryant PJ. The genetics of the protein 4.1 family: Organizers of the membrane and cytoskeleton. Curr Opin Cell Biol. 2000;12:229–234
   PubMed Web of Science ®Google Scholar
• Town M, Jean G, Cherqui S, et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet. 1998;18:319–324
   PubMed Web of Science ®Google Scholar
• Riad A, Zhuo JL, Schultheiss HP, Tschope C. The role of the renal kallikrein-kinin system in diabetic nephropathy. Curr Opin Nephrol Hypertens. 2007;16:22–26
   PubMedGoogle Scholar
• Aliev G, Smith MA, Obrenovich ME, de la Torre JC, Perry G. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotox Res. 2003;5:491–504
   PubMed Web of Science ®Google Scholar
• Hagiwara M, Yamagata K, Capaldi RA, Koyama A. Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis. Kidney Int. 2006;69:1146–1152
   PubMedGoogle Scholar
• Ceriello A, Ihnat MA, Thorpe JE. Clinical review 2: The “metabolic memory”: Is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab. 2009;94:410–415
   PubMed Web of Science ®Google Scholar
• Newman B, Selby JV, King MC, et al. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia. 1987;30:763–768
   PubMed Web of Science ®Google Scholar
• Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 1992;35:1060–1067
   PubMed Web of Science ®Google Scholar
• Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD. Concordance rate for type II diabetes mellitus in monozygotic twins: Actuarial analysis. Diabetologia. 1999;42:146–150
   PubMedGoogle Scholar
• Ballinger SW, Shoffner JM, Hedaya EV, et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet. 1992;1:11–15
   PubMed Web of Science ®Google Scholar
• Rotig A, Bessis JL, Romero N, et al. Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus, and cerebellar ataxia. Am J Hum Genet. 1992;50:364–370
   PubMed Web of Science ®Google Scholar
• Rosen P, Nawroth PP, King G, et al. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001;17:189–212
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820
   PubMed Web of Science ®Google Scholar
• Achilli A, Olivieri A, Pala M, et al. Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole. PLoS One. 2011;6:e21029
   PubMed Web of Science ®Google Scholar
• Cook Jr EH, Scherer SW. Copy-number variations associated with neuropsychiatric conditions. Nature. 2008;455:919–923
   PubMed Web of Science ®Google Scholar
• Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525–528
   PubMed Web of Science ®Google Scholar
• Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36:949–951
   PubMed Web of Science ®Google Scholar
• Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444–454
   PubMed Web of Science ®Google Scholar
• Freeman JL, Perry GH, Feuk L, et al. Copy number variation: New insights in genome diversity. Genome Res. 2006;16:949–961
   PubMed Web of Science ®Google Scholar
• Lieberfarb ME, Lin M, Lechpammer M, et al. Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP. Cancer Res. 2003;63:4781–4785
   PubMed Web of Science ®Google Scholar
• Zhao X, Weir BA, LaFramboise T, et al. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res. 2005;65:5561–5570
   PubMed Web of Science ®Google Scholar
• Grayson BL, Smith ME, Thomas JW, et al. Genome-wide analysis of copy number variation in type 1 diabetes. PLoS One. 2010;5:e15393
   PubMedGoogle Scholar
• Browning BL, Browning SR. Efficient multilocus association testing for whole genome association studies using localized haplotype clustering. Genet Epidemiol. 2007;31:365–375
   PubMedGoogle Scholar
• Zhao J, Jin L, Xiong M. Nonlinear tests for genomewide association studies. Genetics. 2006;174:1529–1538
   PubMedGoogle Scholar
• Rutter M, Moffitt TE, Caspi A. Gene-environment interplay and psychopathology: Multiple varieties but real effects. J Child Psychol Psychiatry. 2006;47:226–261
   PubMed Web of Science ®Google Scholar
• Le Marchand L, Wilkens LR. Design considerations for genomic association studies: Importance of gene–environment interactions. Cancer Epidemiol Biomarkers Prev. 2008;17:263–267
   PubMedGoogle Scholar
• Chapman J, Clayton D. Detecting association using epistatic information. Genet Epidemiol. 2007;31:894–909
   PubMed Web of Science ®Google Scholar
• Hunter DJ. Gene–environment interactions in human diseases. Nat Rev Genet. 2005;6:287–298
   PubMed Web of Science ®Google Scholar
• Thomas DC, Witte JS, Greenland S. Dissecting effects of complex mixtures: Who’s afraid of informative priors? Epidemiology. 2007;18:186–190
   PubMed Web of Science ®Google Scholar
• Kleeberger SR, Peden D. Gene–environment interactions in asthma and other respiratory diseases. Annu Rev Med. 2005;56:383–400
   PubMed Web of Science ®Google Scholar
• O’Rahilly S, Barroso I, Wareham NJ. Genetic factors in type 2 diabetes: The end of the beginning? Science. 2005;307:370–373
   PubMed Web of Science ®Google Scholar
• Han J, Colditz GA, Liu JS, Hunter DJ. Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1539–1544
   PubMedGoogle Scholar
• Liang F, Kume S, Koya D. SIRT1 and insulin resistance. Nat Rev Endocrinol. 2009;5:367–373
   PubMed Web of Science ®Google Scholar
• Miao F, Gonzalo IG, Lanting L, Natarajan R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem. 2004;279:18091–18097
   PubMed Web of Science ®Google Scholar
• Reddy MA, Sahar S, Villeneuve LM, Lanting L, Natarajan R. Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2009;29:387–393
   PubMed Web of Science ®Google Scholar
• Kaur H, Chen S, Xin X, et al. Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300. Diabetes. 2006;55:3104–3111
   PubMedGoogle Scholar
• Xu B, Chiu J, Feng B, Chen S, Chakrabarti S. PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes. Diabetes Metab Res Rev. 2008;24:404–412
   PubMedGoogle Scholar
• Chen S, Feng B, George B, et al. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am J Physiol Endocrinol Metab. 2010;298:E127–E137
   PubMedGoogle Scholar
• Feng B, Chen S, Chiu J, George B, Chakrabarti S. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am J Physiol Endocrinol Metab. 2008;294:E1119–1126
   PubMedGoogle Scholar
• Chakrabarti SK, Francis J, Ziesmann SM, Garmey JC, Mirmira RG. Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells. J Biol Chem. 2003;278:23617–23623
   PubMed Web of Science ®Google Scholar
• Mutskov V, Raaka BM, Felsenfeld G, Gershengorn MC. The human insulin gene displays transcriptionally active epigenetic marks in islet-derived mesenchymal precursor cells in the absence of insulin expression. Stem Cells. 2007;25:3223–3233
   PubMedGoogle Scholar
• Haumaitre C, Lenoir O, Scharfmann R. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. Mol Cell Biol. 2008;28:6373–6383
   PubMed Web of Science ®Google Scholar
• Noh H, Oh EY, Seo JY, et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol. 2009;297:F729–F739
   PubMed Web of Science ®Google Scholar
• Yoshikawa M, Hishikawa K, Marumo T, Fujita T. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. J Am Soc Nephrol. 2007;18:58–65
   PubMed Web of Science ®Google Scholar
• Li Y, Reddy MA, Miao F, et al. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem. 2008;283:26771–26781
   PubMed Web of Science ®Google Scholar
• Brasacchio D, Okabe J, Tikellis C, et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes. 2009;58:1229–1236
   PubMed Web of Science ®Google Scholar
• El-Osta A, Brasacchio D, Yao D, et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med. 2008;205:2409–2417
   PubMed Web of Science ®Google Scholar
• Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31:27–36
   PubMed Web of Science ®Google Scholar
• Kuroda A, Rauch TA, Todorov I, et al. Insulin gene expression is regulated by DNA methylation. PLoS One. 2009;4:e6953
   PubMed Web of Science ®Google Scholar
• Ling C, Del Guerra S, Lupi R, et al. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia. 2008;51:615–622
   PubMed Web of Science ®Google Scholar
• Volkmar M, Dedeurwaerder S, Cunha DA, et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J. 2012;31:1405–1426
   PubMed Web of Science ®Google Scholar
• Bell CG, Teschendorff AE, Rakyan VK, et al. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genom. 2010;3:33
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233
   PubMed Web of Science ®Google Scholar
• Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10:126–139
   PubMed Web of Science ®Google Scholar
• Barski A, Jothi R, Cuddapah S, et al. Chromatin poises miRNA- and protein-coding genes for expression. Genome Res. 2009;19:1742–1751
   PubMedGoogle Scholar
• Kurokawa R, Rosenfeld MG, Glass CK. Transcriptional regulation through noncoding RNAs and epigenetic modifications. RNA Biol. 2009;6:233–236
   PubMed Web of Science ®Google Scholar
• Muhonen P, Holthofer H. Epigenetic and microRNA-mediated regulation in diabetes. Nephrol Dial Transplant. 2009;24:1088–1096
   PubMedGoogle Scholar
• Heneghan HM, Miller N, Kerin MJ. Role of microRNAs in obesity and the metabolic syndrome. Obes Rev. 2010;11:354–361
   PubMed Web of Science ®Google Scholar
• Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432:226–230
   PubMed Web of Science ®Google Scholar
• Poy MN, Spranger M, Stoffel M. microRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab. 2007;9(Suppl 2):67–73
   PubMedGoogle Scholar
• Kato M, Arce L, Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol. 2009;4:1255–1266
   PubMed Web of Science ®Google Scholar
• Kato M, Putta S, Wang M, et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol. 2009;11:881–889
   PubMed Web of Science ®Google Scholar
• Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA. 2007;104:3432–3437
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang Y, Minto AW, et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 2008;22:4126–4135
   PubMed Web of Science ®Google Scholar
• Li S, Chen X, Zhang H, et al. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res. 2009;50:1756–1765
   PubMed Web of Science ®Google Scholar
• Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006;3:87–98
   PubMed Web of Science ®Google Scholar
• Vinciguerra M, Carrozzino F, Peyrou M, et al. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol. 2009;50:1132–1141
   PubMed Web of Science ®Google Scholar
• Cheng LC, Pastrana E, Tavazoie M, Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci. 2009;12:399–408
   PubMed Web of Science ®Google Scholar
• Granjon A, Gustin MP, Rieusset J, et al. The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway. Diabetes. 2009;58:2555–2564
   PubMed Web of Science ®Google Scholar
• Liu N, Williams AH, Kim Y, et al. An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad Sci USA. 2007;104:20844–20849
   PubMed Web of Science ®Google Scholar
• Sayer AA, Dennison EM, Syddall HE, et al. Type 2 diabetes, muscle strength, and impaired physical function: The tip of the iceberg? Diabetes Care. 2005;28:2541–2542
   PubMed Web of Science ®Google Scholar
• Gallagher IJ, Scheele C, Keller P, et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med. 2010;2:9
   PubMedGoogle Scholar
• Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107:810–817
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677–684
   PubMed Web of Science ®Google Scholar
• Tang ZH, Xiao P, Lei SF, et al. A bivariate whole-genome linkage scan suggests several shared genomic regions for obesity and osteoporosis. J Clin Endocrinol Metab. 2007;92:2751–2757
   PubMedGoogle Scholar
• Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet. 2010;42:30–35
   PubMed Web of Science ®Google Scholar
• Sydorova M, Lee MS. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy. Ophthalmic Res. 2005;37:188–190
   PubMed Web of Science ®Google Scholar
• Park HK, Ahn CW, Lee GT, et al. (AC)(n) polymorphism of aldose reductase gene and diabetic microvascular complications in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2002;55:151–157
   PubMed Web of Science ®Google Scholar
• Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002;51:1635–1639
   PubMed Web of Science ®Google Scholar
• Santos KG, Tschiedel B, Schneider J, Souto K, Roisenberg I. Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: Relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes. Diabetes Res Clin Pract. 2003;61:133–136
   PubMed Web of Science ®Google Scholar
• Richeti F, Noronha RM, Waetge RT, et al. Evaluation of AC(n) and C(-106)T polymorphisms of the aldose reductase gene in Brazilian patients with DM1 and susceptibility to diabetic retinopathy. Mol Vis. 2007;13:740–745
   PubMed Web of Science ®Google Scholar
• Uthra S, Raman R, Mukesh BN, et al. Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort. Ophthalmic Genet. 2008;29:11–15
   PubMed Web of Science ®Google Scholar